Conditions: Obesity Interventions: Drug: BI 456906; Drug: Placebo Sponsors: Boehringer Ingelheim Recruiting Author:
Comparison of the Effectiveness of Acupuncture Treatment With Conventional Rehabilitation Methods in Multiple Sclerosis Patients
Conditions: Multiple Sclerosis Interventions: Other: Acupuncture; Other: Conventional Rehabilitation Sponsors: Ankara City Hospital Bilkent Recruiting Clinical Trials online
The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis Patients
Conditions: Multiple Sclerosis Interventions: Other: Blood sample collection Sponsors: German University in Cairo Active, not recruiting Clinical Trials online
Neurostatus-SMARTCARE in Comparison to Standard Neurostatus-EDSS®
Conditions: Multiple Sclerosis (MS) Interventions: Other: Neurostatus-SMARTCARE; Other: Standard Neurostatus-EDSS Sponsors: University Hospital, Basel, Switzerland; Novartis Pharma AG, Basel, Switzerland Active, not recruiting Clinical Trials online
Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies
Conditions: Multiple Sclerosis Interventions: Other: Ofatumumab Sponsors: Novartis Pharmaceuticals Active, not recruiting Clinical Trials online
Effectiveness of Cladribine Tablets in Participants With Highly-active Relapsing Multiple Sclerosis (CAMELOT-MS)
Conditions: Relapsing-Remitting Multiple Sclerosis Sponsors: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany; Merck Serono Limited, an affiliate of Merck KGaA, Darmstadt, Germany Completed Clinical Trials online
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis
Conditions: Multiple Sclerosis (MS) Interventions: Drug: elezanumab; Drug: placebo Sponsors: AbbVie Completed Clinical Trials online
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis
Conditions: Multiple Sclerosis (MS) Interventions: Drug: elezanumab; Drug: placebo Sponsors: AbbVie Completed Clinical Trials online
Live Whole Health #202: Preparing for the New Year
The start of a new year feels like the perfect time to renew our focus on improving our overall health and well-being. Here are two ideas to keep in mind as we kick off 2024. First, we tend to focus more on our “to-do” list than our “have-done” list. Jobs checked off are forgotten while…
Six reasons why military Veterans should consider opening a franchise in 2024
You may be reconsidering your professional future as the new year dawns. For Veterans who don’t want to work for someone else, there’s an option worth considering: Starting a franchise. Owning a business through franchising is a perfect hybrid between working for an organization and starting your own business from scratch. While it’s not for…
Tennessee volunteer given President’s Volunteer Service Award
In the heart of Nashville, Tennessee, there is a remarkable volunteer at Tennessee Valley VA whose dedication has earned him the prestigious President’s Volunteer Service Award. William Pinkleton, a Vietnam Veteran with more than 15 years of volunteer service, embodies the spirit of selfless commitment to his fellow Veterans. Pinkleton’s journey into volunteering began in…
PTSD Bytes: Safety planning to prevent suicide
In this episode of the PTSD Bytes podcast, host Dr. Colleen Becket-Davenport speaks with Dr. Greg Brown, a clinical psychologist at Philadelphia VA, director of the Penn Center for the Prevention of Suicide at the University of Pennsylvania School of Medicine, and one of the creators of the Safety Planning Intervention. They discuss how safety…